Phase I expansion study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in patients with endometrial cancer Meeting Abstract
| Authors: | Martin, L.; Konner, J.; O'Malley, D.; Bauer, T.; Matulonis, U.; Seward, S.; Oza, A.; Kirby, M.; Birrer, M.; Moore, K. |
| Abstract Title: | Phase I expansion study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in patients with endometrial cancer |
| Meeting Title: | 20th International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 27 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Nov 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2017-11-01 |
| Start Page: | 1975 |
| Language: | English |
| ACCESSION: | WOS:000423235205256 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.IGC.0000527296.86225.87 |
| Notes: | Meeting Abstract: ESGO7-1470 -- Source: Wos |
